Massimo Breccia
Policlinico Umberto I · 28 works · 347 citations · h-index 8
Top works
- Factors Affecting Suppression of Endogenous Thyrotropin Secretion by Thyroxine Treatment: Retrospective Analysis in Athyreotic and Goitrous Patients*
- Estrogen and progesterone receptors in benign breast tumors and lesions: Relationship with histological and cytological features
- The long-term durability of cytogenetic responses in patients with accelerated phase chronic myeloid leukemia treated with imatinib 600 mg: the GIMEMA CML Working Party experience after a 7-year follow-up
- Granulocytic Sarcoma with Breast and Skin Presentation: A Report of a Case Successfully Treated by Local Radiation and Systemic Chemotherapy
- Long-term outcome of a phase 2 trial with nilotinib 400 mg twice daily in first-line treatment of chronic myeloid leukemia
- The response to imatinib and interferon- is more rapid than the response to imatinib alone: a retrospective analysis of 495 Philadelphia-positive chronic myeloid leukemia patients in early chronic phase
- Efficacy and safety of second-line ponatinib after failure of a single previous tyrosine kinase inhibitor for chronic myeloid leukemia patients in chronic phase
- Cocaine abuse may influence the response to imatinib in CML patients
- A network-based approach to overcome BCR::ABL1-independent resistance in chronic myeloid leukemia
- Effects of continuous light and dark exposure on hypothalamic thyrotropin-releasing hormone in rats
- Relationship between progesterone receptor, axillary node status and productive fibrosis in ductal infiltrating carcinoma of the breast.
- Serum myoglobin in primary hypothyroidism and effect of L-thyroxine therapy.
- Ontogeny of Nyctohemeral Variations of Thyrotropin- Releasing Hormone in Rat Hypothalamus
- Anemia and blood transfusions in myelofibrosis: economic and organizational impact on Italian patients, caregivers and hospitals
- Outpatient Versus Inpatient Azacitidine Plus Venetoclax Regimen in Elderly Acute Myeloid Leukemia: A Multicenter Retrospective Analysis
- Second-Generation Tyrosine Kinase Inhibitors as First-Line Treatment Strategy in Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia Patients
- Phosphoproteomics reveals novel BCR::ABL1-independent mechanisms of resistance in chronic myeloid leukemia
- La retina, una ulteriore localizzazione extra ipotalamica del thyrotropin-releasing- hormone immunoreattivo (TRH-IR): studi sperimentali e rassegna della letteratura.
- BONE MARROW CYTOKINE CHANGES DURING TREATMENT WITHLENALIDOMIDE IN LOW AND INTERMEDIATE-1 RISK MYELODYSPLASTICSYNDROMES WITH DEL(5Q)
- Correction: A network-based approach to overcome BCR::ABL1-independent resistance in chronic myeloid leukemia